Researchers Discover New Combination of Two Previously Approved FDA Drugs to Treat Lung Cancer
Links shared publicly online about this topic.
A team of researchers led by Dr. Goutham Narla at Case Western Reserve University School of Medicine in collaboration with scientists at Mount Sinai School of Medicine in New York, have discovered a previously unrecognized signaling network disrupted in lung cancer that can be turned back on by a novel combination of two previously approved FDA drugs. The drug combination targets a pathway to treat advanced/late stage lung cancer. The work highlights how understanding the basic mechanisms regula View full resource at newswise.com
Most Recently Shared on June 1, 2012 at 5:25 pm By: